Nicholas DeVito, Assistant Professor of Medicine at Duke University, shared a post on LinkedIn:
“I recently gave a doc talk for COLONTOWN on tumor immunology and immunotherapies like BOT/BAL, highlighting our first-line investigator-initiated trial in MSS CRC. Appreciate the invitation to speak and opportunity to listen to patient/supporter questions!”
You can find more posts featuring Nicholas DeVito in OncoDaily.